It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...

Is it anxiety or a panic attack? Discover the key differences and learn why understanding them matters for managing your ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

The emergency department, while sophisticated and able to treat a variety of medical issues, is not always equipped to ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, summarized its 2024 accomplishments and detailed upcoming 2025 m ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

And GSK said it would pay up to $1.15 billion privately-held IDRx, a clinical-stage biopharmaceutical company developing therapeutics for the treatment of GIST, which stands for Gastrointestinal ...

Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...

Are you worried, restless, or having trouble concentrating most of the time? It could be anxiety. This common mental health ...